Pricing

PALO ALTO INVESTORS LP

5 followers ยท 1 like
PALO ALTO CA Investment Advisor Hedge Fund
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Palo Alto Investors is based out of Palo Alto. Palo Alto Investors is a hedge fund with 12 clients and discretionary assets under management (AUM) of $1,057,000,000 (Form ADV from 2024-03-28). Their last reported 13F filing for Q2 2024 included $862,980,032 in managed 13F securities and a top 10 holdings concentration of 80.4%. Palo Alto Investors's largest holding is Insmed Inc with shares held of 2,138,963. Whalewisdom has at least 103 13F filings, 72 13D filings, 381 13G filings, and 1 Form 4 filings
Business Description
PAI is an investment advisory firm that manages funds and provides investment advice to clients. They engage solicitors to whom they pay cash or a portion of the advisory fees and incentive allocation paid by investors referred to them by those solicitors. This practice is disclosed in writing to investors and PAI complies with the other requirements of Rule 206(4)-1 under the Investment Advisers Act of 1940, to the extent required by applicable law. PAI's funds are managed and reviewed on an ongoing basis by their portfolio managers. These reviews consider asset allocation, cash management, market prospects and individual issue prospects and give particular attention to changes in company earnings, industry outlook, market outlook and price levels. PAI's relationships with brokers that provide soft dollar services influence PAI's judgment and create conflicts of interest in allocating brokerage business between firms that provide soft dollar services and firms that do not. PAI has an incentive to select or recommend a broker based on PAI's interest in receiving soft dollar services rather than any Fund's interest in receiving the most favorable execution. These conflicts of interest are particularly influential to the extent that PAI uses soft dollars to pay expenses it would otherwise be required to pay itself.
Investment Strategy
PAI's investment strategies are general in nature and not exhaustive. There are no limits on the types of securities they may invest in, the concentration of their investments, or the amount of leverage they may use. PAI may use any trading or investment techniques, whether or not contemplated by the expected investment strategies. They may pursue any objectives or use any trading or investment techniques that they consider appropriate and in the Funds' interests. To address potential conflicts, PAI typically allocates all investment opportunities within each strategy pro rata based on each Fund's position size or assets. They also have policies and procedures for reviewing Fund investment allocations on a regular basis.
Owners
(Subscription Required)
Other Contact Information
(Subscription Required)

2024-06-30

Top Buys (13F)

Name % Change
DEBT-ALNY ALNYLAM PHARMACEUTIC (PRN) 5.16%
STAA Staar Surgical Co. 1.67%
SRPT Sarepta Therapeutics 0.75%
ANAB AnaptysBio Inc 0.3%
GBIO Generation Bio Co. 0.05%

2024-06-30

Top Sells (13F)

Name % Change
ALNY Alnylam Pharmaceutic 3.08%
FOLD Amicus Therapeutics 2.03%
ALGN Align Technology Inc 0.76%
EHTH eHealth Inc 0.61%
BMRN BioMarin Pharmaceuti 0.39%

2024-06-30

13F Holdings Summary

Name $ Change
INSM Insmed Inc 16.61%
BMRN BioMarin Pharmaceuti 10.78%
FOLD Amicus Therapeutics 10.38%
UTHR United Therapeutics 9.85%
BIIB Biogen Inc 7.76%

2024-06-30

13F Activity

Market Value $0.86b, Prior: $0.89b
Inflows (Outflows) as % of Total MV (-16.3835)%
New Purchases 2 stocks
Added To 10 stocks
Sold out of 1 stocks
Reduced holdings in 8 stocks
Top 10 Holdings % 80.4%
Turnover %[1] 7.5%
Turnover Alt %[2] 5.41%
Time Held Top 20 20.55 quarters
Time Held Top 10 21.2 quarters
Time Held All 20.1 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2024-06-30

13F Sector Allocation Over Time

limited to past 4 quarters. Subscribe to see all available data

2024-06-30

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2024-06-30

Portfolio Performance